MYC and neoplasm: As the Wnt pathway is known to be pro-proliferative, and has target genes like c-myc and cyclin-D1 [24],[46], in certain contexts including cancers, the fine-tuning or buffering of Wnt activity by several distinct miRs could modulate proliferative potential of tumor cells, which might also explain the observed correlation.